File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.xpro.2023.102506
- Scopus: eid_2-s2.0-85167980480
- WOS: WOS:001059478600001
Supplementary
- Citations:
- Appears in Collections:
Article: Protocol to track the biosynthesis of cholesterol in cultured HCC cells using 13C compound-specific stable isotopic tracers
| Title | Protocol to track the biosynthesis of cholesterol in cultured HCC cells using 13C compound-specific stable isotopic tracers |
|---|---|
| Authors | |
| Keywords | Cancer Cell Culture Chemistry Metabolism |
| Issue Date | 15-Sep-2023 |
| Publisher | Cell Press |
| Citation | STAR Protocols, 2023, v. 4, n. 3 How to Cite? |
| Abstract | Cholesterol biosynthesis supports proliferation and drives resistance to tyrosine kinase inhibitor (TKI) therapy in hepatocellular carcinoma (HCC). Here, we present a protocol for using stable isotopic tracers to track the biosynthesis of cholesterol in cultured HCC cells. We describe steps for cell preparation, incubation, separation, and homogenization. We then detail lipid extraction and compound-specific isotope analysis for comparing and quantifying cholesterol synthesis between TKI-resistant HCC cells and their mock counterparts. This protocol can be expanded for use with other shorter-chained lipids. |
| Persistent Identifier | http://hdl.handle.net/10722/357094 |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Cybulski, JD | - |
| dc.contributor.author | Leung, KS | - |
| dc.contributor.author | Leung, CON | - |
| dc.contributor.author | Baker, DM | - |
| dc.contributor.author | Lee, TKW | - |
| dc.date.accessioned | 2025-06-23T08:53:20Z | - |
| dc.date.available | 2025-06-23T08:53:20Z | - |
| dc.date.issued | 2023-09-15 | - |
| dc.identifier.citation | STAR Protocols, 2023, v. 4, n. 3 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/357094 | - |
| dc.description.abstract | <p>Cholesterol biosynthesis supports proliferation and drives resistance to tyrosine kinase inhibitor (TKI) therapy in hepatocellular carcinoma (HCC). Here, we present a protocol for using stable isotopic tracers to track the biosynthesis of cholesterol in cultured HCC cells. We describe steps for cell preparation, incubation, separation, and homogenization. We then detail lipid extraction and compound-specific isotope analysis for comparing and quantifying cholesterol synthesis between TKI-resistant HCC cells and their mock counterparts. This protocol can be expanded for use with other shorter-chained lipids.</p> | - |
| dc.language | eng | - |
| dc.publisher | Cell Press | - |
| dc.relation.ispartof | STAR Protocols | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | Cancer | - |
| dc.subject | Cell Culture | - |
| dc.subject | Chemistry | - |
| dc.subject | Metabolism | - |
| dc.title | Protocol to track the biosynthesis of cholesterol in cultured HCC cells using 13C compound-specific stable isotopic tracers | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.1016/j.xpro.2023.102506 | - |
| dc.identifier.scopus | eid_2-s2.0-85167980480 | - |
| dc.identifier.volume | 4 | - |
| dc.identifier.issue | 3 | - |
| dc.identifier.eissn | 2666-1667 | - |
| dc.identifier.isi | WOS:001059478600001 | - |
| dc.identifier.issnl | 2666-1667 | - |
